Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx
- PMID: 16265657
- DOI: 10.1002/hed.20272
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx
Abstract
Background: We aimed to identify patterns and predictors of second primary malignancy (SPM) of the aerodigestive tract (SPMADT) in patients with squamous cell carcinoma of the oral cavity (SCCOC) and larynx (SCCL).
Methods: One thousand two hundred fifty-seven patients from two existing databases were studied: 595 with SCCOC (1986-1995) and 662 with SCCL (1984-1998). The primary endpoint of interest was development of SPMADT, defined as a second primary neoplasm of the head and neck, esophagus, or lung.
Results: The 5-year SPMADT rate was 8% in the SCCL versus 10% in the SCCOC subgroup. Lung SPM was more common in the SCCL group; head and neck SPM was more common in the SCCOC group. Smokers had a fivefold increased risk, whereas alcohol use was associated with a twofold increased risk of SPMADT.
Conclusions: The rates of SPMADT after treatment of SCCOC and SCCL are comparable, but the patterns are different. Smoking and alcohol use are independent predictors of SPMADT development.
(c) 2005 Wiley Periodicals, Inc.
Similar articles
-
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11489748 Clinical Trial.
-
Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.J Clin Oncol. 2003 Dec 1;21(23):4336-41. doi: 10.1200/JCO.2003.12.074. J Clin Oncol. 2003. PMID: 14645422
-
Primary and second primary cancer in 649 patients with malignancies of the maxillofacial region.Anticancer Res. 2007 Jul-Aug;27(4A):1805-18. Anticancer Res. 2007. PMID: 17649777
-
Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver.Eur J Cancer Prev. 2008 Aug;17(4):340-4. doi: 10.1097/CEJ.0b013e3282f75e91. Eur J Cancer Prev. 2008. PMID: 18562959 Review.
-
[Second primary cancers after small-cell lung cancer].Bull Cancer. 1997 Aug;84(8):800-6. Bull Cancer. 1997. PMID: 9339185 Review. French.
Cited by
-
Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.J Transl Med. 2022 Sep 5;20(1):405. doi: 10.1186/s12967-022-03544-y. J Transl Med. 2022. PMID: 36064552 Free PMC article.
-
Nutritional implications for quality of life in bladder cancer survivors.Transl Androl Urol. 2018 Dec;7(Suppl 6):S688-S691. doi: 10.21037/tau.2018.12.02. Transl Androl Urol. 2018. PMID: 30687596 Free PMC article. No abstract available.
-
Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.PLoS One. 2022 Feb 15;17(2):e0263773. doi: 10.1371/journal.pone.0263773. eCollection 2022. PLoS One. 2022. PMID: 35167611 Free PMC article.
-
Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.JAMA Otolaryngol Head Neck Surg. 2018 Aug 1;144(8):727-737. doi: 10.1001/jamaoto.2018.0993. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 30027284 Free PMC article.
-
Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.Tumour Biol. 2014 Nov;35(11):10977-85. doi: 10.1007/s13277-014-2392-0. Epub 2014 Aug 5. Tumour Biol. 2014. PMID: 25091574
MeSH terms
LinkOut - more resources
Full Text Sources
Medical